PROVECTUS BIOPHARMACEUTICALS, INC. Up to $50,000,000 of Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementProvectus Biopharmaceuticals, Inc. • April 30th, 2014 • Pharmaceutical preparations • New York
Company FiledApril 30th, 2014 Industry JurisdictionProvectus Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: